ArticleComputational and structural biotechnology journal2024
Keep it accurate and robust: An enhanced nuclei analysis framework.
Article in Computational and structural biotechnology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Digital Pathology-Based Comparison of PyRadiomics and HistomicsTK for Nuclei Classification in Melanoma Whole Slide Images.International journal of biomedical imaging · 2026Article
- PathoEye: A deep learning framework for the whole-slide image analysis of skin tissue.Computational and structural biotechnology journal · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate segmentation and classification of nuclei in histology images is critical but challenging due to nuclei heterogeneity, staining variations, and tissue complexity. Existing methods often struggle with limited dataset variability, with patches extracted from similar whole slide images (WSI), making models prone to falling into local optima. Here we propose a new framework to address this limitation and enable robust nuclear analysis. Our method leverages dual-level ensemble modeling to overcome issues stemming from limited dataset variation. Intra-ensembling applies diverse transformations to individual samples, while inter-ensembling combines networks of different scales. We also introduce enhancements to the HoVer-Net architecture, including updated encoders, nested dense decoding and model regularization strategy. We achieve state-of-the-art results on public benchmarks, including 1st place for nuclear composition prediction and 3rd place for segmentation/classification in the 2022 Colon Nuclei Identification and Counting (CoNIC) Challenge. This success validates our approach for accurate histological nuclei analysis. Extensive experiments and ablation studies provide insights into optimal network design choices and training techniques. In conclusion, this work proposes an improved framework advancing the state-of-the-art in nuclei analysis. We will release our code and models to serve as a toolkit for the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.